4,4'-diisothiocyanostilbene-2,2'-disulfonic acid and Cancer of the Thyroid

4,4'-diisothiocyanostilbene-2,2'-disulfonic acid has been researched along with Cancer of the Thyroid in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Basolo, F; Ciampi, R; Elisei, R; Faviana, P; Pacini, F; Pinchera, A; Santini, F; Traino, C; Vivaldi, A	1

Other Studies

1 other study(ies) available for 4,4'-diisothiocyanostilbene-2,2'-disulfonic acid and Cancer of the Thyroid

Article	Year
Treatment with drugs able to reduce iodine efflux significantly increases the intracellular retention time in thyroid cancer cells stably transfected with sodium iodide symporter complementary deoxyribonucleic acid. The Journal of clinical endocrinology and metabolism, 2006, Volume: 91, Issue:6 Topics: 4,4'-Diisothiocyanostilbene-2,2'-Disulfonic Acid; Benzoquinones; Genetic Therapy; Humans; Iodine; Lactams, Macrocyclic; Rifabutin; Symporters; Thyroid Neoplasms; Transfection	2006

Article

Year

Treatment with drugs able to reduce iodine efflux significantly increases the intracellular retention time in thyroid cancer cells stably transfected with sodium iodide symporter complementary deoxyribonucleic acid.

The Journal of clinical endocrinology and metabolism, 2006, Volume: 91, Issue:6

Topics: 4,4'-Diisothiocyanostilbene-2,2'-Disulfonic Acid; Benzoquinones; Genetic Therapy; Humans; Iodine; Lactams, Macrocyclic; Rifabutin; Symporters; Thyroid Neoplasms; Transfection

2006